Multianalyte tissue-based biomarker panel for endometrial carcinoma screening/confirmation (e.g., protein/genetic markers in tissue samples)
This test examines multiple biomarkers collected from a tissue sample of your endometrium to help assess the presence or risk of endometrial cancer.
["Helps detect or evaluate endometrial cancer by analyzing specific molecular markers in your tissue sample."]
Key facts at a glance
- LOINC
- 105590-4
- Short code
- Endometrial carcinoma multi anl Tiss
- Synonyms
- Endometrial carcinoma multi anl Tiss
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- molgen
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What This Test Measures
The test evaluates a variety of biomarkers—such as proteins, genetic mutations, or other molecular indicators—that may be altered in endometrial cancer. These markers can include tumor suppressors, oncogenes, or other substances that help identify cancerous cells or guide treatment decisions.
Why It’s Done
Your healthcare provider may recommend this test if you have symptoms suggestive of endometrial cancer (e.g., abnormal vaginal bleeding), a high risk due to factors like family history or hormonal conditions, or if you’re undergoing evaluation for suspected endometrial abnormalities.
Sample Collection and Preparation
A tissue sample is obtained during a procedure like a dilation and curettage (D&C) or biopsy. The sample is then analyzed in a laboratory to detect the presence and characteristics of biomarkers associated with endometrial cancer.
Purpose in Diagnosis and Treatment
Results help determine the extent of cancer (staging), guide treatment options (e.g., surgery, chemotherapy), and assess response to therapy. Biomarkers may also provide insights into prognosis or recurrence risk.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This multianalyte approach enhances diagnostic accuracy by identifying multiple potential markers simultaneously, which can improve early detection, refine staging, and tailor personalized treatment plans. Biomarkers may also help monitor disease progression or recurrence over time.
Short name
Endometrial cancer tissue marker panel
Frequently asked questions
What does a positive result mean?
Can this test be used for screening in asymptomatic individuals?
How long does it take to get results?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy